首页> 美国卫生研究院文献>Journal of Experimental Clinical Cancer Research : CR >Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
【2h】

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

机译:正电子发射断层扫描(PET)放射示踪剂在肿瘤学中的应用– 18F氟脱氧葡萄糖(FDG)-PET在非小细胞肺癌(NSCLC)患者治疗中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PET (Positron Emission Tomography) is a nuclear medicine imaging method, frequently used in oncology during the last years. It is a non-invasive technique that provides quantitative in vivo assessment of physiological and biological phenomena. PET has found its application in common practice for the management of various cancers.Lung cancer is the most common cause of death for cancer in western countries.This review focuses on radiotracers used for PET scan with particular attention to Non Small Cell Lung Cancer diagnosis, staging, response to treatment and follow-up
机译:PET(正电子发射断层扫描)是一种核医学成像方法,最近几年在肿瘤学中经常使用。这是一种非侵入性技术,可提供体内生理和生物学现象的定量评估。 PET已发现其在各种癌症管理中的普遍应用。肺癌是西方国家最常见的癌症死亡原因。这篇综述着重于用于PET扫描的放射性示踪剂,特别是对非小细胞肺癌的诊断,分期,对治疗的反应和随访

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号